EP2788030
USES OF IMMUNOCONJUGATES TARGETING CD138
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
7.12.2012EP published:
20.6.2018EP application number:
12798723.8
EPO information:
European Patent Register
Max expiry date:
6.12.2032
Title:
USES OF IMMUNOCONJUGATES TARGETING CD138
Timeline
Today
7.12.2012EP application
20.6.2018EP Publication
Owner
Name:
Biotest AGAddress:
Landsteinerstr. 5, 63303, Dreieich, DE
Name:
ImmunoGen, Inc.Address:
830 Winter Street, 02451, Waltham, MA, US
Inventor
Name:
SCHULZ, GregorAddress:
Umkirch, DE
Name:
OSTERROTH, FrankAddress:
Dietzenbach, DE
Name:
HAEDER, ThomasAddress:
Dreieich, DE
Name:
BRUECHER, ChristophAddress:
Eschborn, DE
Name:
NIEMANN, GabrieleAddress:
Walzbachtal, DE
Name:
ENGLING, AndreAddress:
Bad Homburg, DE
Name:
UHEREK, ChristophAddress:
Seligenstadt, DE
Name:
DAELKEN, BenjaminAddress:
Frankfurt am Main, DE
Name:
WARTENBERG-DEMAND, AndreaAddress:
Schrecksbach, DE
Name:
ZUBER, ChantalAddress:
Ulm, DE
Name:
GUTSCHER, MarcusAddress:
Langen, DE
Name:
BERNOESTER, KatrinAddress:
Wiesbaden, DE
Name:
KOENIG, MartinAddress:
Wiesbaden, DE
Priority
Number:
201161568640 PDate:
8.12.2011Country:
US
Number:
201261722367 PDate:
5.11.2012Country:
US
Classification
Categories:
A61K 47/68, A61P 35/00